Data / Form D filings / Moleculin, LLC
Moleculin, LLC: Form D filings
Moleculin, LLC, a pharmaceuticals company in Houston, TX, filed 10 Form D notices with the SEC between 2011 and 2014. The latest, on October 16, 2014, reports $1.4 million sold of a $2 million offering to 36 investors.
Find out what Moleculin, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1225 NORTH LOOP WEST, SUITE 725, Houston, TX, 77008
- Phone
- 713-953-7676 X 232
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Texas
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 505
- SEC identifier (CIK)
- 1514912
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 16, 2014 | Amendment | $2,000,000 | $1,382,783 | $617,217 | 36 | May 14, 2014 | sec.gov |
| Oct 2, 2014 | Amendment | $2,000,000 | $782,783 | $1,217,217 | 24 | May 14, 2014 | sec.gov |
| May 23, 2014 | Amendment | $2,000,000 | $682,984 | $1,317,016 | 21 | May 14, 2014 | sec.gov |
| May 16, 2014 | New notice | $2,000,000 | $491,010 | $1,508,990 | 13 | May 14, 2014 | sec.gov |
| Jun 14, 2013 | Amendment | $2,019,116 | $2,019,116 | $0 | 64 | Apr 22, 2013 | sec.gov |
| May 21, 2013 | Amendment | $2,018,116 | $1,877,657 | $140,459 | 66 | Apr 22, 2013 | sec.gov |
| Apr 24, 2013 | New notice | $2,000,000 | $1,527,465 | $472,535 | 59 | Apr 22, 2013 | sec.gov |
| Aug 22, 2012 | New notice | $3,250,000 | $3,184,757 | $65,243 | 61 | Apr 9, 2012 | sec.gov |
| Dec 14, 2011 | Amendment | $5,000,000 | $4,490,309 | $509,691 | 8 | Mar 3, 2011 | sec.gov |
| Mar 11, 2011 | New notice | $4,000,000 | $1,165,000 | $2,835,000 | 8 | Mar 3, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Walter V Klemp | Executive Officer, Director | |
| Michael George Clinard | Director | |
| Robert H Conrad | Director | |
| Stephen George Drake | Director | |
| J. George Gumulka | Director | |
| Donald V Picker | Executive Officer, Director | |
| Lori H Bisson | Executive Officer, Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Oct 13, 2014 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Moleculin, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.